Key Insights

Highlights

Success Rate

64% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 67/100

Termination Rate

25.0%

5 terminated out of 20 trials

Success Rate

64.3%

-22.2% vs benchmark

Late-Stage Pipeline

35%

7 trials in Phase 3/4

Results Transparency

33%

3 of 9 completed with results

Key Signals

3 with results64% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (4)
P 1 (2)
P 2 (1)
P 3 (2)
P 4 (5)

Trial Status

Completed9
Terminated5
Withdrawn3
Unknown2
Enrolling By Invitation1

Trial Success Rate

64.3%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (20)

Showing 20 of 20 trials
NCT04550429Not ApplicableTerminatedPrimary

Uterine Filling Pressure in Hysteroscopy

NCT06583395Enrolling By Invitation

Quest to Analyze One Thousand Humans Meditating

NCT04849858Phase 3Terminated

Pilot Study of Liposomal Bupivacaine Redosing in Patients Undergoing Major Gynecologic Procedures

NCT05568940Withdrawn

Evaluating Tibolone Add-back in Patients With Endometriosis and Fibroids

NCT02209545Phase 4TerminatedPrimary

Misoprostol for Reduction of Blood Loss During Fibroid Surgery

NCT02703246Not ApplicableWithdrawnPrimary

Tissue Removal During Hysterectomy: The Effect of Vaginal Versus Abdominal Morcellation on Surgical Outcomes

NCT00001850Terminated

Evaluation of Women With Endocrine and Reproductive-Related Conditions

NCT04071574Phase 1Completed

Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility

NCT02620748Phase 1Completed

Use of Intravenous Tranexamic Acid During Myomectomy

NCT02812186Phase 4Completed

Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery

NCT00710346Terminated

Establishment of Fibroid Tissue Bank

NCT02954744Not ApplicableCompletedPrimary

High-intensity Focused Ultrasound in Treatment of Uterine Fibroid

NCT00995878Phase 4Completed

The FIRSTT: Comparing MRgFUS(MR-guided Focused Ultrasound) Versus UAE (Uterine Artery Embolization)for Uterine Fibroids.

NCT00332033Phase 2Completed

Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids)

NCT01936493Completed

Biologic Predictors of Leiomyoma Treatment Outcomes

NCT02288130Phase 4UnknownPrimary

Ulipristal vs. GnRHa Prior to Laparoscopic Myomectomy

NCT02620345Phase 4CompletedPrimary

Fibroids in Women of Reproductive Age and Women Pregnancy

NCT01671215WithdrawnPrimary

Endometrial and Myometrial Changes, With and Without Fibroids

NCT01581944Phase 3CompletedPrimary

Gonadotropin-releasing Hormone Agonist Prior to Myomectomy

NCT01347385Not ApplicableUnknownPrimary

Barbed Suture Versus Traditional Suture Material for Laparoscopic Myomectomy

Showing all 20 trials

Research Network

Activity Timeline